US lumpectomy market to grow at a CAGR of 4.61% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is presence of venture capitalists. Most of the companies that are focusing on developing lumpectomy products are US-based companies. They are focused on developing novel technologies and to bring those products into the market for which they need funding for R&D and to conduct clinical trials. Hence, both small and large companies, which manufacture lumpectomy products, need funding sources or investors.
According to the report, one driver in the market is the growing incidence of new breast cancer cases. According to various sources, the number of new breast cancer cases has increased by 4-5 folds in the US from 1980 to 2017. According to various studies, obesity and hormone replacement therapies are the key factors that increased the number of breast cancer cases. According to the NCI in 2014, around 89.7% women survived breast cancer during 2007-2013.
Further, the report states that one challenge in the market is the high cost of lumpectomy procedures.
- Carl Zeiss Meditec
- Cianna Medical
- DUNE Medical Devices
- Focal Therapeutics
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Market Sizing
Part 06: Five Forces Analysis
Part 07: Market Segmentation by Product
Part 08: Customer Landscape
Part 09: Market Segmentation by End-Users
Part 10: Decision Framework
Part 11: Drivers and Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/jmv28x/us_lumpectomy?w=4